Inventor
RAJOPADHYE MILIND
US43 patents
⚠️ This page may combine multiple inventors who share the name “RAJOPADHYE MILIND”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB PHARMA CO
20 patentsUS6537520B1Mar 25, 2003
Pharmaceuticals for the imaging of angiogenic disorders
BRISTOL MYERS SQUIBB PHARMA CO91 citations96
US6511648B2Jan 28, 2003
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO35 citations96
US6800273B2Oct 5, 2004
Pharmaceuticals for the imaging of angiogenic disorders
BRISTOL MYERS SQUIBB PHARMA CO46 citations95
US6656448B1Dec 2, 2003
Matrix metalloproteinase inhibitors
BRISTOL MYERS SQUIBB PHARMA CO31 citations92
US6569402B1May 27, 2003
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO24 citations92
US6416733B1Jul 9, 2002
Radiopharmaceuticals for imaging infection and inflammation
BRISTOL MYERS SQUIBB PHARMA CO56 citations92
US6683163B2Jan 27, 2004
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO6 citations74
US7332149B1Feb 19, 2008
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO8 citations73
US6818201B2Nov 16, 2004
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO7 citations73
US6558649B1May 6, 2003
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO6 citations73
US6524554B1Feb 25, 2003
Radiopharmaceuticals for imaging infection and inflammation and for imaging and treatment of cancer
BRISTOL MYERS SQUIBB PHARMA CO12 citations73
US7052673B2May 30, 2006
Pharmaceuticals for the imaging of angiogenic disorders
BRISTOL MYERS SQUIBB PHARMA CO8 citations70
US7321045B2Jan 22, 2008
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO4 citations63
US7060248B2Jun 13, 2006
Matrix metalloproteinase inhibitors
BRISTOL MYERS SQUIBB PHARMA CO2 citations63
US6989139B2Jan 24, 2006
Matrix metalloproteinase inhibitors
BRISTOL MYERS SQUIBB PHARMA CO5 citations63
US6794518B1Sep 21, 2004
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO2 citations63
US6743412B2Jun 1, 2004
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO3 citations63
US6689337B2Feb 10, 2004
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO2 citations63
US7090828B2Aug 15, 2006
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO0 citations52
US7018611B2Mar 28, 2006
Vitronectin receptor antagonist pharmaceuticals
BRISTOL MYERS SQUIBB PHARMA CO0 citations52
VISEN MEDICAL INC
7 patentsUS7947256B2May 24, 2011
Biocompatible fluorescent imaging agents
VISEN MEDICAL INC29 citations92
US9999687B2Jun 19, 2018
Fluorescent imaging agents
VISEN MEDICAL INC9 citations83
US9427481B2Aug 30, 2016
Fluorescent imaging agents
VISEN MEDICAL INC6 citations83
US8771646B2Jul 8, 2014
Nicotinic acid and picolinic acid derived near-infrared fluorophores
VISEN MEDICAL INC14 citations83
US10092188B2Oct 9, 2018
Methods and compositions for identifying subjects at risk of developing stent thrombosis
VISEN MEDICAL INC14 citations82
US9694089B2Jul 4, 2017
Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
VISEN MEDICAL INC5 citations82
US10442930B2Oct 15, 2019
Biocompatible N, N-disubstituted sulfonamide-containing fluorescent dye labels
VISEN MEDICAL INC0 citations51
DU PONT PHARM CO
4 patentsUS6322770B1Nov 27, 2001
Indazole vitronectin receptor antagonist pharmaceuticals
DU PONT PHARM CO69 citations95
US6022523AFeb 8, 2000
Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
DU PONT PHARM CO46 citations94
US5961952AOct 5, 1999
99m Tc-tertiary-butyl isonitrile as breast tumor imaging agents
DU PONT PHARM CO6 citations63
US5888970AMar 30, 1999
Technetium-99m labeled chelator incorporated cyclic peptides that bind to the GPIIb/IIIa receptor as imaging agents
DU PONT PHARM CO3 citations54
RAJOPADHYE MILIND
4 patentsUS8455651B2Jun 4, 2013
Nicotinic acid and picolinic acid derived near-infrared fluorophores
RAJOPADHYE MILIND15 citations92
US8815214B2Aug 26, 2014
Fluorescent imaging agents
RAJOPADHYE MILIND31 citations91
US8173819B2May 8, 2012
Nicotinic and picolinic acid derived near-infrared fluorophores
RAJOPADHYE MILIND23 citations91
US8685370B2Apr 1, 2014
Integrin targeting agents and in-vivo and in-vitro imaging methods using the same
RAJOPADHYE MILIND22 citations90
DU PONT MERCK PHARMA
2 patentsUS5750088AMay 12, 1998
Stable hydrazones linked to a peptide moiety as reagents for the preparation of radiopharmaceuticals
DU PONT MERCK PHARMA49 citations94
US5879657AMar 9, 1999
Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
DU PONT MERCK PHARMA23 citations90